Epsilogen
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$16.4M
Epsilogen specializes in developing immunoglobulin E (IgE) antibodies for cancer treatment, including the first therapeutic IgE antibody to enter clinical trials.
Focus Areas
immunoglobulin E
cancer treatment
clinical trials
ovarian cancer
antibody therapies
proprietary platforms
Investors
